Sorry, you need to enable JavaScript to visit this website.
  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Science & Innovation

Viral vs Bacterial Infections: Different Pathogens, Different Approaches

Learn about the key differences between viral and bacterial infections and the innovative prevention and treatment options being worked on for each type.
Woman sneezing into tissue thumbnail
Science & Innovation

Pharma Peers Unite to Build DNA-Encoded Libraries

Scientists build a library of millions or billions of compounds, each tagged with a unique DNA “barcode.” They are tasked with exploring DNA-encoded libraries technology, DELs, to help accelerate the earliest stages of drug discovery.
Pfizer scientists stacking books cartoon art thumbnail
Science & Innovation

What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States.
Woman checking for ticks thumbnail

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

  • 00Phase 1
  • 00Phase 2
  • 00Phase 3
  • 00Registration
  • 00Total

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details